Arsenic modulates APOBEC3G-mediated restriction to HIV-1 infection in myeloid dendritic cells

Journal of Leukocyte Biology

Volumn 88, Issue 6, 2010, Pages 1251-1258

  Stalder, Romaine ^a   Blanchet, Fabien ^a   Mangeat, Bastien ^a   Piguet, Vincent ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Primary cells; Retrovirus; Subcellular localization

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; ARSENIC TRIOXIDE; RNA;

ARTICLE; CYTOSOLIC FRACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MYELOID DENDRITIC CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ALU ELEMENTS; ANTINEOPLASTIC AGENTS; ARSENICALS; CYTIDINE DEAMINASE; DENDRITIC CELLS; HEK293 CELLS; HIV-1; HUMANS; INTERFERON-ALPHA; MYELOID CELLS; OXIDES; RETROELEMENTS; VIRAL TROPISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78649723101     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0310176     Document Type: Article

References (37)

1. Loré, K., Smed-Sorensen, A., Vasudevan, J., Mascola, J. R., Koup, R. A. (2005) Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J. Exp. Med. 201, 2023-2033.
2. Granelli-Piperno, A., Shimeliovich, I., Pack, M., Trumpfheller, C., Steinman, R. M. (2006) HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J. Immunol. 176, 991-998.
3. Moris, A., Pajot, A., Blanchet, F., Guivel-Benhassine, F., Salcedo, M., Schwartz, O. (2006) Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108, 1643-1651.
4. Wu, L., KewalRamani, V. N. (2006) Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6, 859-868.
5. Piguet, V., Steinman, R. M. (2007) The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol. 28, 503-510. (Pubitemid 350087807)
6. Gilliet, M., Cao, W., Liu, Y. J. (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606.
7. Fonteneau, J. F., Larsson, M., Beignon, A. S., McKenna, K., Dasilva, I., Amara, A., Liu, Y. J., Lifson, J. D., Littman, D. R., Bhardwaj, N. (2004) Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78, 5223-5232.
8. Pion, M., Arrighi, J. F., Jiang, J., Lundquist, C. A., Hartley, O., Aiken, C., Piguet, V. (2007) Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels. J. Invest. Dermatol. 127, 319-323.
9. Cavrois, M., Neidleman, J., Kreisberg, J. F., Fenard, D., Callebaut, C., Greene, W. C. (2006) Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J. Virol. 80, 1992-1999.
10. Pion, M., Granelli-Piperno, A., Mangeat, B., Stalder, R., Correa, R., Steinman, R. M., Piguet, V. (2006) APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J. Exp. Med. 203, 2887-2893.
11. Pion, M., Stalder, R., Correa, R., Mangeat, B., Towers, G. J., Piguet, V. (2007) Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells. J. Virol. 81, 12086-12090.
12. Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., Wahl, S. M. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393-400.
13. Koning, F. A., Newman, E. N., Kim, E. Y., Kunstman, K. J., Wolinsky, S. M., Malim, M. H. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83, 9474-9485.
14. Stopak, K. S., Chiu, Y. L., Kropp, J., Grant, R. M., Greene, W. C. (2007) Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J. Biol. Chem. 282, 3539-3546.
15. Wang, F. X., Huang, J., Zhang, H., Ma, X. (2008) APOBEC3G upregulation by α interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. J. Gen. Virol. 89, 722-730.
16. Trapp, S., Derby, N. R., Singer, R., Shaw, A., Williams, V. G., Turville, S. G., Bess Jr., J. W., Lifson, J. D., Robbiani, M. (2009) Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J. Virol. 83, 884-895.
17. Ogawa, Y., Kawamura, T., Kimura, T., Ito, M., Blauvelt, A., Shimada, S. (2009) Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113, 5157-5166.
18. Low, A., Okeoma, C. M., Lovsin, N., de las Heras, M., Taylor, T. H., Peterlin, B. M., Ross, S. R., Fan, H. (2009) Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 385, 455-463.
19. Sui, Y., Zhu, Q., Gagnon, S., Dzutsev, A., Terabe, M., Vaccari, M., Venzon, D., Klinman, D., Strober, W., Kelsall, B., Franchini, G., Belyakov, I. M., Berzofsky, J. A. (2010) Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc. Natl. Acad. Sci. USA 107, 9843-9848.
20. Chiu, Y. L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., Greene, W. C. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435, 108-114.
21. Kamata, M., Nagaoka, Y., Chen, I. S. (2009) Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells. PLoS Pathog. 5, e1000342.
22. Santoni de Sio, F. R., Trono, D. (2009) APOBEC3G-depleted resting CD4+ T cells remain refractory to HIV1 infection. PLoS One 4, e6571.
23. Vetter, M. L., Johnson, M. E., Antons, A. K., Unutmaz, D., D'Aquila, R. T. (2009) Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity. PLoS Pathog. 5, e1000292.
24. Vetter, M. L., D'Aquila, R. T. (2009) Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helpersubtype cells. J. Virol. 83, 8646-8654.
25. Keckesova, Z., Ylinen, L. M., Towers, G. J. (2006) Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 α antiviral activity. J. Virol. 80, 4683-4690.
26. Sebastian, S., Sokolskaja, E., Luban, J. (2006) Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner. J. Virol. 80, 2051-2054.
27. Berthoux, L., Towers, G. J., Gurer, C., Salomoni, P., Pandolfi, P. P., Luban, J. (2003) As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J. Virol. 77, 3167-3180.
28. Blanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., Schwartz, O., Deretic, V., Piguet, V. (2010) Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32, 654-669.
29. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., Trono, D. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875. (Pubitemid 127747819)
30. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., Yee, J. K. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
31. Clavel, F., Charneau, P. (1994) Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68, 1179-1185.
32. Smed-Sorensen, A., Lore, K., Vasudevan, J., Louder, M. K., Andersson, J., Mascola, J. R., Spetz, A. L., Koup, R. A. (2005) Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J. Virol. 79, 8861-8869.
33. Chen, K., Huang, J., Zhang, C., Huang, S., Nunnari, G., Wang, F. X., Tong, X., Gao, L., Nikisher, K., Zhang, H. (2006) α Interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J. Virol. 80, 7645-7657.
34. Chiu, Y. L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T., Greene, W. C. (2006) High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl. Acad. Sci. USA 103, 15588-15593.
35. Bishop, K. N., Verma, M., Kim, E. Y., Wolinsky, S. M., Malim, M. H. (2008) APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4, e1000231.
36. Goujon, C., Riviere, L., Jarrosson-Wuilleme, L., Bernaud, J., Rigal, D., Darlix, J. L., Cimarelli, A. (2007) SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 4, 2.
37. Kozak, S. L., Marin, M., Rose, K. M., Bystrom, C., Kabat, D. (2006) The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J. Biol. Chem. 281, 29105-29119.